March 21, 2023
Re-analysing Ebola spread in Sierra Leone: The importance of local social dynamics

Re-analysing Ebola spread in Sierra Leone: The importance of local social dynamics

Background: The 2013-15 Ebola epidemic in West Africa was the biggest up to now recorded, and primarily affected three adjoining nations, Guinea, Liberia and Sierra Leone. The worst affected nation (by way of confirmed circumstances) was Sierra Leone. The current paper seems to be on the epidemic in Sierra Leone. The epidemic on this nation was a concatenation of native outbreaks. These native outbreaks are usually not properly characterised by evaluation utilizing commonplace numerical methods. Partly, this displays difficulties in file assortment on the peak of the epidemic. This paper presents a unique method, based mostly on utility of field-based methods of social investigation that present a richer understanding of the epidemic.
Strategies: In a post-epidemic research (2016-18) of two districts (Bo and Moyamba) we use ethnographic information to reconstruct native an infection pathways from proof offered by affected communities, cross-referenced to information of the epidemic retained by the Nationwide Ebola Response Fee, now lodged within the Ebola Museum and Archive at Njala College. Our research paperwork and discusses native social and contextual elements largely lacking from beforehand revealed research.
Outcomes: Our main discovering is that the epidemic in Sierra Leone was a collection of native outbreaks, a few of which had been higher contained than others. In people who weren’t properly contained, various contingent elements helps clarify lack of management. A number of numerical research have drawn consideration to the significance of native heterogeneities within the Sierra Leone Ebola epidemic. Our qualitative research throws particular mild on various components that designate these heterogeneities: the position of externalities, well being system deficiencies, cultural concerns and native coping capacities.
Conclusions: Social points and native contingencies clarify the unfold of Ebola in Sierra Leone and are key to understanding heterogeneities in epidemiological information. Integrating ethnographic analysis into epidemic-response is crucial to correctly perceive the patterns of unfold and the alternatives to intervene. This conclusion has vital implications for future interdisciplinary analysis and interpretation of ordinary numerical information, and consequently for management of epidemic outbreaks.

Analysis of novel HIV vaccine candidates utilizing recombinant vesicular stomatitis virus vector produced in serum-free Vero cell cultures

Acquired Immune Deficiency Syndrome (AIDS) in people is a results of the destruction of the immune system attributable to Human Immunodeficiency Virus (HIV) an infection. This critical epidemic continues to be progressing world-wide. Regardless of advances in therapy, a protected and efficient preventive HIV vaccine is desired to fight this illness, and to save lots of hundreds of thousands of lives. Nonetheless, such a vaccine shouldn’t be accessible but though in depth quantities of assets in analysis and improvement have been invested over three a long time. In mild of the not too long ago accepted Ebola virus illness vaccine based mostly on a recombinant vesicular stomatitis virus (rVSV-ZEBOV), we current the outcomes of our work on three novel VSV-vectored HIV vaccine candidates. We describe the design, rescue, manufacturing and purification methodology and consider their immunogenicity in mice previous to preclinical research that will likely be carried out in non-human primates.
The manufacturing of every of the three candidate vaccines (rVSV-B6-NL4.3Env/SIVtm, rVSV-B6-NL4.3Env/Ebtm and rVSV-B6-A74Env(PN6)/SIVtm) was evaluated in small scale in Vero cells and it was discovered that manufacturing kinetics on Vero cells differ relying on the HIV gp floor protein used. Purified virus preparations complied with the WHO restrictions for the residual DNA and host cell protein contents. Lastly, when administered to mice, all three rVSV-HIV vaccine candidates induced an HIV gp140-specific antibody response. Greater than 423349 deaths had occurred globally and continues to be growing each day. The entire world is beneath a well being emergency, and individuals are suggested to remain at their houses to keep away from the unfold of person-to-person an infection, and suggested to keep up social distancing.
The development in medical analysis methods like Actual-Time PCR (RT-PCR), immunological, microscopy, and geographic data system (GIS) mapping expertise helped in tacking the fast analysis and monitoring viral an infection in a brief interval. In the identical means, synthetic intelligence (AI), combinatorial chemistry, and deep studying approaches assist to search out novel therapeutics in much less time and extensive applicability in biomedical analysis. Nationwide Institute of Allergy and Infectious Illnesses (NIAID) has began the medical trials of investigation COVID-19 vaccine. Due to this fact, we will anticipate vaccines to be accessible for this lethal illness within the coming few months.
Re-analysing Ebola spread in Sierra Leone: The importance of local social dynamics
Re-analysing Ebola spread in Sierra Leone: The importance of local social dynamics

Screening for Anti-Influenza Actives of Prefractionated Conventional Chinese language Medicines

Moreover, all of the ten hit fractions inhibited the propagation of progeny influenza virus considerably at 20 μg/mL. The hit TCM fractions deserve additional isolation for accountable constituents main in the direction of anti-influenza medication. Furthermore, a library consisting of 500 simplified TCM extracts was established, facilitating antiviral screening in fast response to rising and re-emerging viruses reminiscent of Ebola virus and present SARS-CoV-2 pandemic. Phosphatidylserine (PS) receptors mediate clearance of apoptotic cells-efferocytosis-by recognizing the PS uncovered on these cells. Additionally they mediate the entry of enveloped viruses by binding PS within the virion membrane. Right here we present that phosphatidylethanolamine (PE) synergizes with PS to boost PS receptor-mediated efferocytosis and virus entry.

Hepatitis B Virus antibody

10-H05K 1 mg
EUR 159.6
Description: Mouse monoclonal Hepatitis B Virus antibody

Hepatitis B Virus antibody

10-H05M 1 mg
EUR 159.6
Description: Mouse monoclonal Hepatitis B Virus antibody

Influenza B Virus Antibody

abx022028-1mg 1 mg
EUR 1220.4

Influenza B Virus Antibody

abx022029-1mg 1 mg
EUR 1220.4

Influenza B Virus Antibody

abx022030-1mg 1 mg
EUR 1220.4

Virus Grapevine Virus B (GVB) ELISA Kit

abx055779-96tests 96 tests
EUR 801.6

Fmoc-b,b-diphenyl-Ala-OH

B-2725.0250 250.0mg
EUR 166.8
Description: Sum Formula: C30H25NO4; CAS# [201484-50-6]

Fmoc-b,b-diphenyl-Ala-OH

B-2725.1000 1.0g
EUR 428.4
Description: Sum Formula: C30H25NO4; CAS# [201484-50-6]

Fmoc-b,b-diphenyl-Ala-OH

B-2725.5000 5.0g
EUR 1603.2
Description: Sum Formula: C30H25NO4; CAS# [201484-50-6]

Analyte Mix B

507-B 1ML
EUR 182.4

Analyte Mix B

5081-B 1ML
EUR 129.96

Phenolics Mix B

8040-B 1ML
EUR 61.56

Influenza B virus Nucleoprotein (NP)

1-CSB-YP356318IJU
  • EUR 814.80
  • EUR 402.00
  • EUR 2606.40
  • EUR 1261.20
  • EUR 1730.40
  • EUR 522.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Influenza B virus Nucleoprotein(NP) ,partial expressed in Yeast

Influenza B virus Nucleoprotein (NP)

1-CSB-YP361330IJK
  • EUR 814.80
  • EUR 402.00
  • EUR 2606.40
  • EUR 1261.20
  • EUR 1730.40
  • EUR 522.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Influenza B virus Nucleoprotein(NP) expressed in Yeast

Influenza B virus ELISA Kit

DEIA1195 48T
EUR 471.6
Description: The Influenza B viru ELISA Kit is designed to detect and quantify the level Influenza B virus of in serum.

Influenza B virus Nucleoprotein (NP)

1-CSB-BP361330IJK
  • EUR 1008.00
  • EUR 398.40
  • EUR 2604.00
  • EUR 1362.00
  • EUR 1894.80
  • EUR 564.00
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Influenza B virus Nucleoprotein(NP) expressed in Baculovirus

Influenza B virus Nucleoprotein (NP)

1-CSB-EP356318IJU(F1)
  • EUR 733.20
  • EUR 370.80
  • EUR 2192.40
  • EUR 1126.80
  • EUR 1461.60
  • EUR 476.40
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Influenza B virus Nucleoprotein(NP) expressed in E.coli

Influenza B virus Nucleoprotein (NP)

1-CSB-EP356318IJU
  • EUR 733.20
  • EUR 370.80
  • EUR 2192.40
  • EUR 1126.80
  • EUR 1461.60
  • EUR 476.40
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Influenza B virus Nucleoprotein(NP) ,partial expressed in E.coli

Influenza B virus Nucleoprotein (NP)

1-CSB-EP361330IJK
  • EUR 733.20
  • EUR 370.80
  • EUR 2192.40
  • EUR 1126.80
  • EUR 1461.60
  • EUR 476.40
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Influenza B virus Nucleoprotein(NP) expressed in E.coli

Hepatitis B Virus PreS2 antibody

70R-HR002 100 ug
EUR 484.8
Description: Affinity purified Rabbit polyclonal Hepatitis B Virus PreS2 antibody

Recombinant Hepatitis B Virus x

7-07420 5µg Ask for price

Recombinant Hepatitis B Virus x

7-07421 25µg Ask for price

Recombinant Hepatitis B Virus x

7-07422 1000µg Ask for price

Recombinant Hepatitis B Virus HBe    

7-07426 100µg Ask for price

Recombinant Hepatitis B Virus HBe    

7-07427 500µg Ask for price

Recombinant Hepatitis B Virus HBe    

7-07428 1000µg Ask for price

Influenza B Virus Nucleoprotein antibody

10R-2122 100 ul
EUR 483.6
Description: Mouse monoclonal Influenza B Virus Nucleoprotein antibody

Hepatitis B Virus preS1 antibody

10-H07A 1 mg
EUR 405.6
Description: Mouse monoclonal Hepatitis B Virus preS1 antibody

Hepatitis B Virus preS1 antibody

10-H07B 1 mg
EUR 405.6
Description: Mouse monoclonal Hepatitis B Virus preS1 antibody

Hepatitis B Virus preS2 antibody

10-H08A 1 mg
EUR 405.6
Description: Mouse monoclonal Hepatitis B Virus preS2 antibody

Anti-Hepatitis B Virus Antibody

A30379 100ug/vial
EUR 400.8

Influenza B virus Nucleoprotein Antibody

20-abx109424
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Influenza B virus Nucleoprotein Antibody

20-abx110601
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Hepatitis B Virus (HBV) Antibody

20-abx137061
  • EUR 427.20
  • EUR 627.60
  • 0.5 mg
  • 1 mg

Influenza B virus Nucleoprotein Antibody

abx016031-100ul 100 ul
EUR 493.2

Hepatitis B Virus HBe Protein

20-abx260125
  • EUR 1062.00
  • EUR 410.40
  • EUR 1646.40
  • 0.5 mg
  • 100 ug
  • 1 mg

Hepatitis B Virus x Protein

20-abx262147
  • EUR 6373.20
  • EUR 393.60
  • EUR 276.00
  • 1 mg
  • 25 ug
  • 5 ug

Influenza B Virus Hemagglutinin Antibody

abx411429-02mg 0.2 mg
EUR 678

Hepatitis B virus PCR kit

PCR-H494-48D 50T
EUR 543.6

Hepatitis B virus PCR kit

PCR-H494-96D 100T
EUR 686.4

Anti-Hepatitis B virus antibody

STJ16100722 100 µg
EUR 487.2

Anti-Hepatitis B virus antibody

STJ16100723 100 µg
EUR 487.2

Influenza B Virus Qingdao 102/91 (purified virus, inactivated)

RP-1526 10 ug
EUR 270

Influenza B Virus Tokio 53/99 (purified virus, inactivated)

RP-1527 10 ug
EUR 270

Influenza B Virus Florida 04/06 (purified virus, inactivated)

RP-1591 10 ug
EUR 270

Influenza B Virus Malaysia 2506/04 (purified virus, inactivated)

RP-1592 10 ug
EUR 270

Rat Anti-Influenza B virus Ig’s(Anti-Influenza B virus Ig’s) ELISA Kit

QY-E11692 96T
EUR 448.8

Fmoc-b-Ala-OH

B-1025.0005 5.0g
EUR 138
Description: Sum Formula: C18H17NO4; CAS# [35737-10-1]

Fmoc-b-Ala-OH

B-1025.0025 25.0g
EUR 283.2
Description: Sum Formula: C18H17NO4; CAS# [35737-10-1]

Fmoc-b-Ala-OH

B-1025.0100 100.0g
EUR 762
Description: Sum Formula: C18H17NO4; CAS# [35737-10-1]

Fmoc-b-Ala-OPfp

B-1765.0005 5.0g
EUR 283.2
Description: Sum Formula: C24H16F5NO4; CAS# [149303-38-8]

Fmoc-b-Ala-OPfp

B-1765.0025 25.0g
EUR 1009.2
Description: Sum Formula: C24H16F5NO4; CAS# [149303-38-8]

Purgeable Gases Mix B

5022-B 1ML
EUR 27.36

Purgeable Gases Mix B

624-B 1ML
EUR 249.66

Fmoc-b-cyclohexyl-Ala-OH

B-1975.0001 1.0g
EUR 151.2
Description: Sum Formula: C24H27NO4; CAS# [135673-97-1]

Fmoc-b-cyclohexyl-Ala-OH

B-1975.0005 5.0g
EUR 501.6
Description: Sum Formula: C24H27NO4; CAS# [135673-97-1]

Fmoc-b-cyclohexyl-Ala-OH

B-1975.0025 25.0g
EUR 1430.4
Description: Sum Formula: C24H27NO4; CAS# [135673-97-1]

Fmoc-b-cyclopropyl-Ala-OH

B-2905.0001 1.0g
EUR 414
Description: Sum Formula: C21H21NO4; CAS# [214750-76-2]

Fmoc-b-cyclopropyl-Ala-OH

B-2905.0005 5.0g
EUR 1561.2
Description: Sum Formula: C21H21NO4; CAS# [214750-76-2]

Polynuclear Aromatic Hydrocarbons Mix B

8100-B 1ML
EUR 788.88

Hepatitis B Virus X antigen Antibody

48299-100ul 100ul
EUR 399.6

Hepatitis B Virus X antigen Antibody

48299-50ul 50ul
EUR 286.8

Hepatitis B Virus Receptor Binding Fragment

5-01296 4 x 1mg Ask for price

Hepatitis B virus core Recombinant Protein

53-315 0.01 mg
EUR 619.8
Description: Hepatitis B virus core Recombinant Protein

Hepatitis B virus core Recombinant Protein

53-316 0.01 mg
EUR 651.3
Description: Hepatitis B virus core Recombinant Protein

Hepatitis B virus core Recombinant Protein

53-322 0.01 mg
EUR 852.9
Description: Hepatitis B virus core Recombinant Protein

Recombinant Hepatitis B Virus Core Delta

7-07417 100µg Ask for price

Recombinant Hepatitis B Virus Core Delta

7-07418 500µg Ask for price

Recombinant Hepatitis B Virus Core Delta

7-07419 1000µg Ask for price

Recombinant Hepatitis B Virus e-Antigen

7-07423 5µg Ask for price

Recombinant Hepatitis B Virus e-Antigen

7-07424 25µg Ask for price

Recombinant Hepatitis B Virus e-Antigen

7-07425 1000µg Ask for price

Influenza B Virus Qingdao 102/91

7-07906 10µg Ask for price

Influenza B Virus Qingdao 102/91

7-07907 50µg Ask for price

Influenza B Virus Qingdao 102/91

7-07908 1mg Ask for price

Influenza B Virus Tokio 53/99

7-07909 10µg Ask for price

Influenza B Virus Tokio 53/99

7-07910 50µg Ask for price

Influenza B Virus Tokio 53/99

7-07911 1mg Ask for price

Influenza B Virus Victoria 504/00

7-07912 10µg Ask for price

Influenza B Virus Victoria 504/00

7-07913 50µg Ask for price

Influenza B Virus Victoria 504/00

7-07914 1mg Ask for price

Influenza B Virus Malaysia 2506/04

7-07915 10µg Ask for price

Influenza B Virus Malaysia 2506/04

7-07916 50µg Ask for price

Influenza B Virus Malaysia 2506/04

7-07917 1mg Ask for price

Influenza B Virus Florida 07/04

7-07918 10µg Ask for price

Influenza B Virus Florida 07/04

7-07919 50µg Ask for price

Influenza B Virus Florida 07/04

7-07920 1mg Ask for price

Influenza B Virus Florida 04/06

7-07921 10µg Ask for price

Influenza B Virus Florida 04/06

7-07922 50µg Ask for price

Influenza B Virus Florida 04/06

7-07923 1mg Ask for price

HBcAg [Hepatitis B virus] (18-27)

A1140-1 1 mg
EUR 129.6
Description: HBcAg (core antigen) is a hepatitis B viral protein(1)(2). It is an indicator of active viral replication; this means the person infected with Hepatitis B can likely transmit the virus on to another person.

HBcAg [Hepatitis B virus] (18-27)

A1140-10 10 mg
EUR 408
Description: HBcAg (core antigen) is a hepatitis B viral protein(1)(2). It is an indicator of active viral replication; this means the person infected with Hepatitis B can likely transmit the virus on to another person.

HBcAg [Hepatitis B virus] (18-27)

A1140-5 5 mg
EUR 268.8
Description: HBcAg (core antigen) is a hepatitis B viral protein(1)(2). It is an indicator of active viral replication; this means the person infected with Hepatitis B can likely transmit the virus on to another person.

Mouse antibody for Influenza B virus

1133 100 ug
EUR 431.93
Description: This is Mouse monoclonal FITC conjugated antibody against Influenza B virus NP for WB, ELISA.

Influenza B virus Nucleoprotein Antibody (HRP)

20-abx109160
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Influenza B virus Nucleoprotein Antibody (HRP)

20-abx109161
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Influenza B virus Nucleoprotein Antibody (Biotin)

20-abx106329
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Influenza B virus Nucleoprotein Antibody (Biotin)

20-abx106330
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Influenza B virus Nucleoprotein Antibody (FITC)

20-abx107742
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Influenza B virus Nucleoprotein Antibody (FITC)

20-abx107743
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Hepatitis B Virus Pre-S1 Antibody

abx145169-100ug 100 ug
EUR 469.2

Hepatitis B Virus Core Antigen Antibody

20-abx133947
  • EUR 427.20
  • EUR 644.40
  • EUR 260.40
  • 100 ul
  • 200 ul
  • 30 ul

Hepatitis B Virus Core Antigen Antibody

20-abx133948
  • EUR 427.20
  • EUR 644.40
  • EUR 260.40
  • 100 ul
  • 200 ul
  • 30 ul

Hepatitis B Virus E Antigen Antibody

20-abx134030
  • EUR 427.20
  • EUR 644.40
  • EUR 260.40
  • 100 ul
  • 200 ul
  • 30 ul

Hepatitis B Virus E Antigen Antibody

20-abx134031
  • EUR 427.20
  • EUR 644.40
  • EUR 260.40
  • 100 ul
  • 200 ul
  • 30 ul

Hepatitis B Virus Surface Antigen Antibody

20-abx134235
  • EUR 427.20
  • EUR 644.40
  • EUR 260.40
  • 100 ul
  • 200 ul
  • 30 ul

Hepatitis B Virus Surface Antigen Antibody

20-abx134236
  • EUR 427.20
  • EUR 644.40
  • EUR 260.40
  • 100 ul
  • 200 ul
  • 30 ul

Human Influenza B Virus ELISA Kit

abx052829-96tests 96 tests
EUR 801.6

HbcAg - Hepatitis B Virus Core; Polyclonal

A20060 2 ml
EUR 94.8

Anti-Influenza B Virus Polyclonal Antibody

A2086-50 50 µl
EUR 381.6

Hepatitis B Virus Core delta Protein

20-abx260228
  • EUR 1062.00
  • EUR 410.40
  • EUR 1930.80
  • 0.5 mg
  • 100 ug
  • 1 mg

Hepatitis B Virus x Interacting Protein

20-abx260780
  • EUR 4101.60
  • EUR 393.60
  • EUR 276.00
  • 1 mg
  • 20 ug
  • 5 ug

Hepatitis B Virus e-Antigen Protein

20-abx260781
  • EUR 4101.60
  • EUR 393.60
  • EUR 276.00
  • 1 mg
  • 25 ug
  • 5 ug

Hepatitis B virus core recombinant antigen

8914 100 ug
EUR 673.36
Description: This is Hepatitis B virus core recombinant antigen for ELISA,WB.

Hepatitis B virus core recombinant antigen

8927 100 ug
EUR 412.36
Description: This is Hepatitis B virus core recombinant antigen for ELISA,WB.

Hepatitis B virus core recombinant antigen

8929 100 ug
EUR 477.6
Description: This is Hepatitis B virus core recombinant antigen for ELISA,WB.

HbcAg - Hepatitis B Virus Core; Polyclonal

A00060 6 ml
EUR 129.6

HbcAg - Hepatitis B Virus Core; Polyclonal

A00060.0025 25 ml
EUR 302.4

anti-Influenza B virus Nucleoprotein (1A2A11)

LF-MA30147 100 ul
EUR 583.2
Description: Mouse Monoclonal to Influenza B virus Nucleoprotein

Hepatitis B virus RT PCR kit

RTq-H494-100D 100T
EUR 860.4

Hepatitis B virus RT PCR kit

RTq-H494-150D 150T
EUR 969.6

Hepatitis B virus RT PCR kit

RTq-H494-50D 50T
EUR 717.6

Anti-Influenza B virus Nucleoprotein antibody

STJ98178 100 µl
EUR 280.8
Description: Mouse monoclonal to Influenza B virus Nucleoprotein.

QPCR Kit DNA Hepatitis B virus

MOL6942 EACH
EUR 839.04

Virus Hepatitis B Virus Surface Antigen ay (HBsAg ay) Protein

abx670099-01mg 0.1 mg
EUR 678

Virus Hepatitis B Virus Surface Antigen ad (HBsAg ad) Protein

abx670255-01mg 0.1 mg
EUR 844.8

Fmoc-b-azido-Aib-OH · BHA

B-4530.0001 1.0g
EUR 846
Description: Sum Formula: C19H18N4O4·C13H13N; CAS# [1926163-90-7] net

Fmoc-b-(2-thienyl)-Ala-OH

B-1665.0001 1.0g
EUR 340.8
Description: Sum Formula: C22H19NO4S; CAS# [130309-35-2]

Fmoc-b-(2-thienyl)-Ala-OH

B-1665.0005 5.0g
EUR 1255.2
Description: Sum Formula: C22H19NO4S; CAS# [130309-35-2]

Fmoc-b-(3-pyridyl)-Ala-OH

B-2005.0001 1.0g
EUR 471.6
Description: Sum Formula: C23H20N2O4; CAS# [175453-07-3]

Fmoc-b-(3-pyridyl)-Ala-OH

B-2005.0005 5.0g
EUR 1778.4
Description: Sum Formula: C23H20N2O4; CAS# [175453-07-3]

Fmoc-b-cyclohexyl-D-Ala-OH

B-2345.0001 1.0g
EUR 181.2
Description: Sum Formula: C24H27NO4; CAS# [144701-25-7]

Fmoc-b-cyclohexyl-D-Ala-OH

B-2345.0005 5.0g
EUR 618
Description: Sum Formula: C24H27NO4; CAS# [144701-25-7]

Fmoc-b-cyclohexyl-D-Ala-OH

B-2345.0025 25.0g
EUR 2358
Description: Sum Formula: C24H27NO4; CAS# [144701-25-7]

Fmoc-b-(3-benzothienyl)-Ala-OH

B-2830.0001 1.0g
EUR 254.4
Description: Sum Formula: C26H21NO4S; CAS# [177966-60-8]

Fmoc-b-(3-benzothienyl)-Ala-OH

B-2830.0005 5.0g
EUR 907.2
Description: Sum Formula: C26H21NO4S; CAS# [177966-60-8]

Fmoc-b-cyclopropyl-D-Ala-OH

B-2915.0001 1.0g
EUR 704.4
Description: Sum Formula: C21H21NO4; CAS# [170642-29-2]

Fmoc-b-cyclopropyl-D-Ala-OH

B-2915.0005 5.0g
EUR 2706
Description: Sum Formula: C21H21NO4; CAS# [170642-29-2]

Fmoc-b-(2-quinolyl)-Ala-OH

B-3165.0250 250.0mg
EUR 457.2
Description: Sum Formula: C27H22N2O4; CAS# [214852-56-9]
The presence of PE on the identical floor as PS dramatically enhances recognition of PS by PS-binding proteins reminiscent of GAS6, PROS, and TIM1. Liposomes containing each PE and PS certain to GAS6 and had been engulfed by AXL-expressing cells way more effectively than these containing PS alone. Additional, an infection of AXL-expressing cells by infectious Zika virus or Ebola, Chikungunya or japanese equine encephalitis pseudoviruses was inhibited with better effectivity by the liposomes containing each PS and PE in comparison with a mix of liposomes individually composed of PS and PE.

Leave a Reply

Your email address will not be published.